The HIV drug resistance report; 2012 (Sólo en inglés)

This report reviews data on HIV drug resistance in low- and middle-income countries between 2003 and 2010 and three main conclusions stand out. First, with the expansion of treatment achieved over the last eight years, there are signals of increasing prevalence of transmitted HIV drug resistance, particularly to non-nucleoside reverse transcriptase inhibitors (NNRTI), among recently infected populations in the areas surveyed. However, though increasing, transmitted HIV drug resistance has not occurred at the high levels some had predicted as a consequence of the rapid scale-up of antiretroviral therapy